Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Joy Ghosh, PhD

Joy Ghosh, PhD

Vice President
Life Sciences


Joy Ghosh joined Bain Capital Life Sciences in 2017. Prior to joining Bain Capital, Dr. Ghosh was a Sr. Manager in Corporate Development and Strategy at Biogen. Prior to Biogen, Dr. Ghosh was an Investigator and Project Leader at the Novartis Institutes of Biomedical Research from 2009-2016. At Novartis, Dr. Ghosh led projects from idea generation to clinical proof-of-concept studies, including two novel antibodies that are currently in Ph. I/II human proof-of-concept studies in neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. At Novartis, Dr. Ghosh’s lab was responsible for the design and development of novel protein and antibody therapeutics for over 10 different programs in Ophthalmology and Immunology.


Dr. Ghosh received his Ph.D. in Biomolecular Structure and Design from the University of Washington along with a Certificate in Innovation and Entrepreneurship from the Foster School of Business. Dr. Ghosh was a Senior Scholar at Harvard Medical School/Brigham and Women’s Hospital and Boston University.

Dr. Ghosh received a BS in Biochemistry from the University of Texas at Austin.